Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Carmot Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10938
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company that discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company provides product portfolio such as encompasses investigational candidates in preclinical trials: peptide-small molecule hybrid compounds that target Nonalcoholic Steatohepatitis NASH. It offers products such as protein-protein interactions NEMO and IKK for the treatment of cancer and inflammation; and GLP-1R and GIPR for treating Type 2 diabetes and obesity, among others. Carmot Therapeutics proprietary technology, Chemotype Evolution applies to identify and optimize innovative drugs for various therapeutic areas. The company works in collaboration with research institutions and companies such as Amgen Inc and Genentech for discovery of new drugs. Carmot Therapeutics is headquartered in Berkeley, California, the US.

Carmot Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Carmot Therapeutics Raises USD15 Million in Series B Financing 10
Carmot Therapeutics Raises USD10.8 Million in Venture Financing 11
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 12
Licensing Agreements 13
Amgen Enters into Licensing Agreement with Carmot Therapeutics 13
Amgen Expands its Licensing Agreement with Carmot Therapeutics 14
Genentech Enters into Licensing Agreement with Carmot Therapeutics 15
Carmot Therapeutics Inc – Key Competitors 16
Carmot Therapeutics Inc – Key Employees 17
Carmot Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Carmot Therapeutics Raises USD15 Million in Series B Financing 10
Carmot Therapeutics Raises USD10.8 Million in Venture Financing 11
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 12
Amgen Enters into Licensing Agreement with Carmot Therapeutics 13
Amgen Expands its Licensing Agreement with Carmot Therapeutics 14
Genentech Enters into Licensing Agreement with Carmot Therapeutics 15
Carmot Therapeutics Inc, Key Competitors 16
Carmot Therapeutics Inc, Key Employees 17
Carmot Therapeutics Inc, Other Locations 18

List of Figures
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Carmot Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Storopack Hans Reichenecker GmbH:企業の戦略的SWOT分析
    Storopack Hans Reichenecker GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Premiere Global Services, Inc.:企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Kanoria Chemicals & Industries Ltd (KANORICHEM):企業の財務・戦略的SWOT分析
    Kanoria Chemicals & Industries Ltd (KANORICHEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Las Vegas Sands Corp:戦略・SWOT・企業財務分析
    Las Vegas Sands Corp - Strategy, SWOT and Corporate Finance Report Summary Las Vegas Sands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Exact Sciences Corp (EXAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • Vinci SA:企業のM&A・事業提携・投資動向
    Vinci SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vinci SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • PT Lotte Shopping Indonesia:企業の戦略・SWOT・財務分析
    PT Lotte Shopping Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Lotte Shopping Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CryoTherapeutics Gmbh:医療機器:M&Aディール及び事業提携情報
    Summary CryoTherapeutics GmbH (CryoTherapeutics) is a medical equipment company that offers systemic drug based approach in combination with a localised device-based therapy. The company offers proprietary cryotherapy system that used for the treatment of coronary artery disease that causes heart at …
  • Porto Seguro SA:企業の戦略・SWOT・財務分析
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lloyds Banking Group Plc:戦略・SWOT・企業財務分析
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ContextVision AB (COV):企業の財務・戦略的SWOT分析
    Summary ContextVision AB (ContextVision) is a medical technology company that specializes in image analysis and artificial intelligence software solutions. The company develops image enhancement software solutions for magnetic resonance imaging, digital pathology, ultrasound, X-ray, fluoroscopy, mam …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Acona Holding AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Acona Holding AS (Acona) is an oil and gas company that offers well management and cleaning technology services. The company’s services include drilling and well technology services, exploration and production technology, field development, and oil and gas consulting services. It also provid …
  • Rockwool International AS:戦略・SWOT・企業財務分析
    Rockwool International AS - Strategy, SWOT and Corporate Finance Report Summary Rockwool International AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Huesker Synthetic GmbH:企業の戦略・SWOT・財務情報
    Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report Summary Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Komax Holding AG (KOMN):企業の財務・戦略的SWOT分析
    Komax Holding AG (KOMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Vivartia Holdings SA.:企業の戦略的SWOT分析
    Vivartia Holdings SA. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MILEI GmbH:戦略・SWOT・企業財務分析
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • NeuroSearch AS (NEUR):企業の財務・戦略的SWOT分析
    NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆